William Blair Initiates Coverage on The Pennant Group (NASDAQ:PNTG)

Research analysts at William Blair began coverage on shares of The Pennant Group (NASDAQ:PNTG) in a research note issued on Monday. The brokerage set an “outperform” rating on the stock.

A number of other research firms have also weighed in on PNTG. Weiss Ratings restated a “hold (c)” rating on shares of The Pennant Group in a research note on Monday, December 1st. Stephens reaffirmed an “overweight” rating and issued a $40.00 target price on shares of The Pennant Group in a report on Thursday, October 9th. Royal Bank Of Canada upped their price target on The Pennant Group from $34.00 to $39.00 and gave the stock an “outperform” rating in a research report on Monday, November 17th. Truist Financial upgraded The Pennant Group from a “hold” rating to a “buy” rating and boosted their price objective for the company from $28.00 to $34.00 in a research note on Tuesday, December 2nd. Finally, Jefferies Financial Group began coverage on shares of The Pennant Group in a research note on Friday, October 24th. They set a “buy” rating and a $30.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Buy” and a consensus price target of $34.80.

The Pennant Group Price Performance

PNTG stock opened at $29.21 on Monday. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08. The Pennant Group has a 12 month low of $21.18 and a 12 month high of $31.39. The firm has a market capitalization of $1.01 billion, a P/E ratio of 38.95, a price-to-earnings-growth ratio of 2.37 and a beta of 1.31. The firm has a 50 day moving average of $25.68 and a 200-day moving average of $25.72.

The Pennant Group (NASDAQ:PNTG) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.01. The firm had revenue of $229.04 million during the quarter, compared to the consensus estimate of $221.96 million. The Pennant Group had a return on equity of 9.37% and a net margin of 3.15%.The Pennant Group has set its FY 2025 guidance at 1.140-1.180 EPS. As a group, sell-side analysts predict that The Pennant Group will post 0.75 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. CIBC Private Wealth Group LLC boosted its stake in The Pennant Group by 651.8% in the 3rd quarter. CIBC Private Wealth Group LLC now owns 3,398 shares of the company’s stock worth $86,000 after purchasing an additional 2,946 shares in the last quarter. Provident Investment Management Inc. purchased a new stake in shares of The Pennant Group in the third quarter valued at approximately $6,685,000. Dark Forest Capital Management LP acquired a new position in The Pennant Group during the third quarter worth $1,173,000. PharVision Advisers LLC acquired a new position in shares of The Pennant Group in the 3rd quarter valued at $222,000. Finally, Turtle Creek Asset Management Inc. lifted its position in The Pennant Group by 84.6% in the third quarter. Turtle Creek Asset Management Inc. now owns 12,000 shares of the company’s stock valued at $303,000 after buying an additional 5,500 shares during the last quarter. 85.88% of the stock is owned by institutional investors.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.